Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials

[1]  L. Hooper,et al.  Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials , 2019, The British Journal of Psychiatry.

[2]  F. Song,et al.  Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials , 2020, British Journal of Cancer.

[3]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[4]  Douglas G. Altman,et al.  Analysing data and undertaking meta‐analyses , 2019, Cochrane Handbook for Systematic Reviews of Interventions.

[5]  Julii Brainard,et al.  Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials , 2019, BMJ.

[6]  F. Song,et al.  The Relationship Between Omega-3, Omega-6 and Total Polyunsaturated Fat and Musculoskeletal Health and Functional Status in Adults: A Systematic Review and Meta-analysis of RCTs , 2019, Calcified Tissue International.

[7]  F. Song,et al.  Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews , 2019, BMJ Open.

[8]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[9]  F. Song,et al.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[10]  F. Song,et al.  Omega-6 fats for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[11]  F. Song,et al.  Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[12]  W. Willett,et al.  Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance , 2018, British Medical Journal.

[13]  Orestis Efthimiou,et al.  Practical guide to the meta-analysis of rare events , 2018, Evidence Based Journals.

[14]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[15]  L. Hooper,et al.  Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease:Protocol , 2017 .

[16]  L. Hooper,et al.  Effects of supplementary dietary polyunsaturated fat on cancer incidence:Protocol , 2017 .

[17]  R. Breau,et al.  Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review , 2016, Integrative cancer therapies.

[18]  I. Khorsand,et al.  Effects of flaxseed and Hypericum perforatum on hot flash, vaginal atrophy and estrogen-dependent cancers in menopausal women: a systematic review and meta-analysis , 2016, Avicenna journal of phytomedicine.

[19]  G. P. Herbison,et al.  Impact of analysing continuous outcomes using final values, change scores and analysis of covariance on the performance of meta‐analytic methods: a simulation study , 2015, Research synthesis methods.

[20]  F. Hu,et al.  Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial. , 2015, JAMA internal medicine.

[21]  Richard M. Martin,et al.  A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality , 2015, Cancer Causes & Control.

[22]  C. Summerbell,et al.  Effects of total fat intake on body weight. , 2015, The Cochrane database of systematic reviews.

[23]  B. Kimler,et al.  Omega-3 fatty acids for breast cancer prevention and survivorship , 2015, Breast Cancer Research.

[24]  Bo Norrving,et al.  Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. , 2015, Stroke.

[25]  Rainer Malisch,et al.  Dioxins and PCBs in feed and food--review from European perspective. , 2014, The Science of the total environment.

[26]  P. Hajeb,et al.  Toxic Elements in Food: Occurrence, Binding, and Reduction Approaches. , 2014, Comprehensive reviews in food science and food safety.

[27]  S. Sagar,et al.  Flax and Breast Cancer , 2014, Integrative cancer therapies.

[28]  Yu-hao Zhou,et al.  Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials , 2014, BMC Public Health.

[29]  Richard J. K. Taylor,et al.  A review of life expectancy and infant mortality estimations for Australian Aboriginal people , 2014, BMC Public Health.

[30]  I. Thompson,et al.  Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. , 2014, Journal of the National Cancer Institute.

[31]  Ju-Sheng Zheng,et al.  Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies , 2013, BMJ.

[32]  橋本 卓也.  留学体験記 (Imperial College London) , 2012 .

[33]  Ross J. Harris,et al.  Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. , 2012, Health technology assessment.

[34]  P. Calder,et al.  Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish1234 , 2012, The American journal of clinical nutrition.

[35]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[36]  I. Thompson,et al.  Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. , 2011, American journal of epidemiology.

[37]  Eric J Feuer,et al.  Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.

[38]  M. Roizen.  Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort , 2011 .

[39]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[40]  J. Matés,et al.  Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. , 2010, Free radical biology & medicine.

[41]  J. Potter,et al.  Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[42]  P. Kogner,et al.  Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? , 2010, Experimental cell research.

[43]  P. Barnes,et al.  Complementary and alternative medicine use among adults and children: United States, 2007. , 2008, National health statistics reports.

[44]  D. Altman,et al.  Assessing Risk of Bias in Included Studies , 2008 .

[45]  Douglas G Altman,et al.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.

[46]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[47]  Salvatore Panico,et al.  Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC) , 2006, International journal of cancer.

[48]  Julian P T Higgins,et al.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review , 2006, BMJ : British Medical Journal.

[49]  R. Burger,et al.  Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study , 2005, BMJ : British Medical Journal.

[50]  Alexander J Sutton,et al.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. , 2004, Statistics in medicine.

[51]  Explore Configuring.  A Simulation Study to , 2004 .

[52]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[53]  C. Diggle.  In vitro studies on the relationship between polyunsaturated fatty acids and cancer: tumour or tissue specific effects? , 2002, Progress in lipid research.

[54]  A. Trichopoulou,et al.  Cancer and Mediterranean dietary traditions. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  D G Altman,et al.  Confidence intervals for the number needed to treat , 1998, BMJ.

[56]  N Mamelle,et al.  Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. , 1998, Archives of internal medicine.

[57]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[58]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[59]  J. Salmon.  Dietary reference values : a guide , 1991 .

[60]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[61]  Marie Manthey,et al.  A GUIDE FOR , 1967 .